STORRS, Connecticut, May 22 -- The University of Connecticut posted the following news: * * * 'We Are Not Simply Training Musicians' - A Conversation with Interim Provost Pamir Alpay * If you ask the accomplished Ukrainian-born concert violinist Solomiya Ivakhiv if she's worried about the impact of artificial intelligence on her work as an artist and performer, she'll answer frankly. "You can't replace humans," she says. For Ivakhiv - who has performed solo and chamber music in venues ar  more

INGELHEIM AM RHEIN, Germany, May 23 -- Boehringer Ingelheim, a pharmaceutical company, issued the following news release: * * * China approves HERNEXEOS as first targeted oral treatment option for HER2-mutant advanced NSCLC at initial diagnosis * Therapy approved based on Phase Ib Beamion LUNG-1 trial data, demonstrating robust efficacy (75.7% objective response rate) in treatment-naive patients/1 * Expedited approval as an initial treatment in China follows U.S. accelerated approval for HER  more